Regenerative is the category everyone in aesthetics is talking about, which is precisely why it deserves an owner's skepticism before it gets an injector's enthusiasm. It's simultaneously the most hyped area in the field and the one carrying the most regulatory landmines, and those two facts are related: hype runs ahead of clarity, demand runs ahead of regulation, and the gap between "patients want this" and "you can legally offer it the way the marketing implies" is exactly where practices walk into trouble. Sorting the bookable reality from the buzz — and the legally defensible from the merely popular — is a job for the owner, upstream of any clinical decision.
This is general education for owners, not legal or medical advice. Regulatory status in this category is evolving and product-specific; confirm sourcing and footing with counsel and current guidance.